# Price T Rowe Group Inc: overview

TROW · Nasdaq · CIK 1113169 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/trow.md) · [Financials](/companies/trow/financials.md) · [Filings](/companies/trow/filings.md) · [Insiders](/companies/trow/insiders.md)

Latest reported revenue: [$2.00bn](/filings/0001113169-26-000005.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 29, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001113169-26-000005).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,825 d](/filings/0001628280-26-008002.md) | [1,764](/filings/0001628280-26-028712.md) | [1,723](/filings/0001628280-26-051335.md) | [1,894](/filings/0001113169-26-000005.md) | [1,934 d](/filings/0001628280-26-008002.md) | [1,857](/filings/0001628280-26-028712.md) | [1,907](/filings/0001628280-26-051335.md) | [2,005](/filings/0001113169-26-000005.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [31.2% d](/filings/0001628280-26-008002.md) | [33.8%](/filings/0001628280-26-028712.md) | [27.8%](/filings/0001628280-26-051335.md) | [34.0%](/filings/0001113169-26-000005.md) | [24.4% d](/filings/0001628280-26-008002.md) | [36.6%](/filings/0001628280-26-028712.md) | [28.3%](/filings/0001628280-26-051335.md) | [38.4%](/filings/0001113169-26-000005.md) |
| Net margin | % | [24.1% d](/filings/0001628280-26-008002.md) | [27.8%](/filings/0001628280-26-028712.md) | [29.3%](/filings/0001628280-26-051335.md) | [34.1%](/filings/0001113169-26-000005.md) | [23.0% d](/filings/0001628280-26-008002.md) | [26.8%](/filings/0001628280-26-028712.md) | [33.1%](/filings/0001628280-26-051335.md) | [30.5%](/filings/0001113169-26-000005.md) |
| Diluted EPS | $ per share | not reported | [2.15](/filings/0001628280-26-028712.md) | [2.24](/filings/0001628280-26-051335.md) | [2.87](/filings/0001113169-26-000005.md) | not reported | [2.23](/filings/0001628280-26-028712.md) | [2.88](/filings/0001628280-26-051335.md) | [2.79](/filings/0001113169-26-000005.md) |
| Free cash flow | $m | [(395) d](/filings/0001628280-26-008002.md) | [551](/filings/0001628280-26-028712.md) | [468 d](/filings/0001628280-26-051335.md) | [546 d](/filings/0001113169-26-000005.md) | [(85.4) d](/filings/0001628280-26-008002.md) | [762](/filings/0001628280-26-028712.md) | [451 d](/filings/0001628280-26-051335.md) | [471 d](/filings/0001113169-26-000005.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [7,672](/filings/0001113169-24-000007.md) | [6,488](/filings/0001113169-25-000007.md) | [6,461](/filings/0001628280-26-008002.md) | [7,094](/filings/0001628280-26-008002.md) | [7,315](/filings/0001628280-26-008002.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [48.4%](/filings/0001113169-24-000007.md) | [36.6%](/filings/0001113169-25-000007.md) | [30.7%](/filings/0001628280-26-008002.md) | [32.9%](/filings/0001628280-26-008002.md) | [29.9%](/filings/0001628280-26-008002.md) |
| Net margin | % | [40.2%](/filings/0001113169-24-000007.md) | [24.0%](/filings/0001113169-25-000007.md) | [27.7%](/filings/0001628280-26-008002.md) | [29.6%](/filings/0001628280-26-008002.md) | [28.5%](/filings/0001628280-26-008002.md) |
| Diluted EPS | $ per share | [13.12](/filings/0001113169-24-000007.md) | [6.70](/filings/0001113169-25-000007.md) | [7.76](/filings/0001628280-26-008002.md) | [9.15](/filings/0001628280-26-008002.md) | [9.24](/filings/0001628280-26-008002.md) |
| Free cash flow | $m | [3,213](/filings/0001113169-24-000007.md) | [2,122](/filings/0001113169-25-000007.md) | [911](/filings/0001628280-26-008002.md) | [1,262](/filings/0001628280-26-008002.md) | [1,479](/filings/0001628280-26-008002.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/trow/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $2.73bn | 23,996,119 |  | Added +1,226,444 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $1.67bn | 14,653,478 |  | Added +381,183 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.59bn | 13,972,686 |  | Reduced −188,785 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.14bn | 10,042,805 |  | Reduced −126,778 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $961.0m | 8,452,903 |  | Added +3,185 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $814.4m | 7,163,538 |  | Added +548,834 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $709.9m | 6,263,829 |  | Reduced −22,478 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $468.0m | 4,116,868 |  | Added +239,438 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $449.7m | 3,955,664 |  | Reduced −161,227 |
| [Fayez Sarofim & Co](/funds/937729.md) | 2026-06-30 | $446.1m | 3,923,459 |  | Reduced −511,902 |

## Recent filings

[All 1,970 filings](/companies/trow/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 13:57 ET | [10-Q](/filings/0001113169-26-000005.md) | Quarterly report, period 2026-09-30 | 0001113169-26-000005 |
| 2026-10-29 | 07:05 ET | [8-K](/filings/0001113169-26-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001113169-26-000003 |
| 2026-07-31 | 12:59 ET | [10-Q](/filings/0001628280-26-051335.md) | Quarterly report, period 2026-06-30 | 0001628280-26-051335 |
| 2026-07-31 | 07:03 ET | [8-K](/filings/0001628280-26-051211.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-051211 |
| 2026-05-18 | 16:00 ET | [8-K](/filings/0001628280-26-035912.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-035912 |
| 2026-05-11 | 16:01 ET | [8-K](/filings/0001628280-26-033420.md) | 5.07 Shareholder vote results | 0001628280-26-033420 |
| 2026-04-30 | 12:41 ET | [10-Q](/filings/0001628280-26-028712.md) | Quarterly report, period 2026-03-31 | 0001628280-26-028712 |
| 2026-04-30 | 07:02 ET | [8-K](/filings/0001628280-26-028572.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-028572 |
| 2026-04-22 | 08:00 ET | [8-K](/filings/0001628280-26-026397.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-026397 |
| 2026-03-17 | 06:16 ET | [DEF 14A](/filings/0001104659-26-028876.md) | Proxy statement, period 2026-05-07 | 0001104659-26-028876 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-008002.md), filed Feb 13, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/54f214ed-346b-4e9d-90fc-c29ec26b39f2)

## About the filer

- CIK: 1113169
- Tickers: TROW
- Exchange: Nasdaq
- SIC code: 6282 Investment Advice
- State of incorporation: MD
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 14:06 ET. No prices; not investment advice.